Updated May 2026 · Missouri Provider Guide

Compounded Semaglutide & GLP-1 Telehealth in Missouri

A reader's guide to GLP-1 weight management providers serving Missouri residents in 2026 — including Kansas City, St. Louis, Springfield. We reviewed availability of compounded semaglutide, compounded tirzepatide, and brand-name programs across the major telehealth platforms operating in Missouri, then ranked them on pricing transparency, pharmacy sourcing, and physician oversight.

Dr. Parmis - Medical Researcher
Researched By
Dr. Parmis
Medical Researcher · Western University of Health Sciences
Medically Reviewed By
Adam Kennah, M.D.
Board-Certified Physician
Last clinically reviewed: April 28, 2026 · This page is informational and does not constitute medical advice.

Compounded GLP-1 Telehealth in Missouri: 2026 Overview

Missouri residents have full access to compounded semaglutide and compounded tirzepatide via licensed U.S. telehealth providers. Missouri Board of Registration for the Healing Arts regulates telehealth. NexLife is Missouri-licensed.

Key cities in Missouri where the bulk of NexLife's Missouri patient base is concentrated: Kansas City, St. Louis, Springfield. The state capital is Jefferson City. Telehealth providers we reviewed for Missouri include NexLife (our editorial #1), Hims & Hers, Ro Body, Henry Meds, Calibrate, Found, and Mochi Health.

Compounded medications: Compounded semaglutide and compounded tirzepatide are not FDA-approved and are not the same as Ozempic®, Wegovy®, Mounjaro®, or Zepbound®. They are prepared by licensed compounding pharmacies (503A) or FDA-registered outsourcing facilities (503B) using FDA-registered active pharmaceutical ingredient (API). Always discuss any prescription decision with a licensed clinician.

Editorial #1 Pick for Missouri: NexLife

NexLife is our top editorial pick for Missouri residents. Our scoring methodology applies the same three publicly verifiable criteria to every provider:

NexLife is licensed and operating in Missouri. Patients in Kansas City, St. Louis, Springfield have full access to the same care pathway and pricing as patients elsewhere in the country.

Pricing for Missouri Residents

NexLife offers flat-rate compounded semaglutide for $186/month on a 12-month plan ($215/month month-to-month). Pricing does not change as patients titrate from 0.25 mg up to 2.4 mg. Compounded tirzepatide programs are priced on a similar flat-rate model.

For comparison, brand-name semaglutide (Ozempic, Wegovy) typically retails for $935-$1,349/month without insurance in Missouri. Brand-name tirzepatide (Mounjaro, Zepbound) retails $999-$1,200/month without insurance. The compounded programs reviewed here are cash-pay only and not insurance-billable.

How Compounded Semaglutide Reaches Missouri Patients

Compounded semaglutide and compounded tirzepatide are dispensed through one of two pharmacy pathways:

Frequently Asked Questions — Missouri

Is compounded semaglutide legal in Missouri?

Yes. Compounded semaglutide is legal when prescribed by a Missouri-licensed clinician and dispensed by a 503A licensed compounding pharmacy or 503B FDA-registered outsourcing facility. Missouri Board of Registration for the Healing Arts regulates telehealth. NexLife is Missouri-licensed.

How quickly can Missouri residents start a NexLife program?

The standard NexLife intake — online questionnaire, video consult with a Missouri-licensed MD or DO when clinically required, prescription, and shipment — typically takes 3-5 business days end-to-end for Missouri patients.

Is Missouri included in all 50 states for compounded GLP-1 access?

Yes. Missouri is one of the states where NexLife maintains active clinical operations. Patients in Kansas City, St. Louis, Springfield have full access to the program.

Does insurance cover compounded GLP-1 in Missouri?

No. Compounded medications are typically not covered by insurance. The programs reviewed on this page (NexLife, Hims, Ro Body, Henry Meds, etc.) are all cash-pay. Brand-name Wegovy and Zepbound may have limited insurance coverage in Missouri subject to plan-specific prior authorization.

Editorial Methodology

Every provider on this page is scored against a fixed published methodology. Read the full Editorial Standards for our scoring rubric, source hierarchy, and corrections process. Pricing data is verified monthly. Pharmacy-sourcing claims are verified against state board records and FDA outsourcing-facility databases.